Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 531681 | NSE Symbol : | ISIN : INE673C01020 | Industry : Finance & Investments |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
12-May-2025	19-May-2025	Accounts	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve PFA PFA (As Per BSE Announcement dated on 19.05.2025)
22-Jan-2025	03-Feb-2025	Change in Directors	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve Pursuantto Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 3rd February 2025 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2024. 2.) To approve and consider the appointment of Mr. Kelash Bunkar as Director of the Company. 3.) To consider the resignation of Mr. Niraj Vaghela from directorship of the Company. 4.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 3rd February 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st December 2024. 2.) The board has considered and accepted the resignation of Independent Director Mr Niraj Vaghela w e.f 03.02.2025. 3.) Mr. Kelash Bunkar is appointed as non-executive independent director of the company w e f. 03.02.2025 subject to approval of members in AGM. The board meeting commenced at 05:40 PM and concluded at 06:00 PM Please take the above intimation in your records. (As Per BSE Announcement Dated on: 03/02/2025)
15-Oct-2024	22-Oct-2024	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2024 inter alia to consider and approve PFA Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Tuesday 22th October 2024 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September, 2024. The board meeting commented at 01.30 PM and concluded at 02.05 PM Read less.. (As Per BSE Announcement Dated on 22.10.2024)
30-Jul-2024	06-Aug-2024	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 6th August 2024 inter alia to consider following business. Please take the above intimation in your records. Thanking You. PFA (As per BSE Announcement Dated on 06/08/2024)
16-May-2024	23-May-2024	Accounts	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 23rd May 2024 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financia l Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. Audited Financial Results of the company for the quarter and year ended on 31st March 2024. Outcome of the Board Meeting held on 23rd May 2024. (As per BSE Announcement Dated on 23/05/2024)
16-Jan-2024	22-Jan-2024	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday January 22 2024 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You. PFA (As Per BSE Announcement dated on 13.02.2024)
26-Oct-2023	07-Nov-2023	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Tuesday November 7 2023 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2023 and also transact other business activities. Please take the above intimation in your records. Thanking you. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2023 and The meeting commenced at 04.00P.M. and concluded at 04.30 P.M. Kindly take the same on your record and oblige. Thanking You PFA (As Per BSE Announcement Dated on 07/11/2023)
03-Aug-2023	08-Aug-2023	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 8th August 2023 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 8th August 2023 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2023. The board meeting concluded on 04.15. P.M Please take the above intimation in your records. Thanking You, PFA (As Per BSE Announcement dated on 08.08.2023)
27-Apr-2023	04-May-2023	Accounts	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 4th May 2023 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2023. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. This is to inform you that Outcome of the Board Meeting of the Company held on Thursday 4th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 03.50 P.M. Request you to kindly take on record the same. (As per BSE Announcement Dated on 04/05/2023)
18-Jan-2023	25-Jan-2023	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday January 25 2023 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2022 also transact other business activities. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2022 and board meeting concluded on 03.45 P.M. Kindly take the same on your record and oblige. Thanking You. (As per BSE Announcement Dated on 25/01/2023)
04-Nov-2022	12-Nov-2022	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Saturday November 12 2022 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2022 and also transact other business activities. Please take the above intimation in your records. Thanking you. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Un-audited financial result for quarter and half year ended on 30th September, 2022 and board meeting concluded on 02.05 P.M. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated 12.11.2022)
28-Jul-2022	08-Aug-2022	Quarterly Results	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 3rd August 2022. inter alia to consider following business.- 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You The Board Meeting to be held on 03/08/2022 has been revised to 08/08/2022 Sub: Reschedule of Board Meeting as per Compliance of Regulation 29 of SEBI (LODR) Regulations, 2015 - Intimation of Board meeting. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company to be held on 3rd August 2022 is postponed and rescheduled on 8th August 2022 interalia, to consider following business.- 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2022. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. (As Per BSE Announcement Dated 02.08.2022) Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 8th August 2022 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2022. Please take the above intimation in your records. Thanking You. (As Per BSE Announcement Dated on 08/08/2022)
20-May-2022	28-May-2022	Accounts	Amerise Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Saturday 28th May 2022 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2022. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. This is to inform you that Outcome of the Board Meeting of the Company held on Saturday 28th May 2022 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2022. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2022. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2022 with unmodified opinion. Request you to kindly take on record the same. Thanking You. (As per BSE Announcement Dated on 28.05.2022)
25-Jan-2022	14-Feb-2022	Quarterly Results	AMRADEEP INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday February 14 2022 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2021 also transact other business activities. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith unaudited financial result for quarter ended 31st December 2021. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated 14.02.2022)
28-Oct-2021	12-Nov-2021	Quarterly Results	Quarterly Results Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Friday November 12, 2021 at the Registered Office of the Company and transacted the following major businesses. Please take the above intimation in your records. Thanking You. (As per BSE Announcement Dated on 12/11/2021)

1 2

LOGIN HERE

Amerise Biosciences Ltd

Board Meeting